the obligation to record and report suspected adverse events for their veterinary medicinal products, in accordance with Article 76(2);
an oibleagáid teagmhais dhíobhálacha amhrasta le haghaidh a gcuid táirgí íocshláinte tréidliachta a thaifead agus a thuairisciú, i gcomhréir le hAirteagal 76(2);